Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Obstetrics & Gynecology
Volume 126, Issue 5
November 2015 Pages 917 - 927

Changes in use of long-acting reversible contraceptive methods among United States women, 2009-2012

Megan L. Kavanaugh,Guttmacher Institute
Jenna Jerman
Lawrence B. Finer
The time is now. Will you stand up for reproductive health and rights?
Donate Now
First published online: November 16, 2015 DOI: https://doi.org/10.1097/AOG.0000000000001094

Objective: To examine current levels, current correlates of, and changes in long-acting reversible contraceptive (LARC) use, including intrauterine devices and implants, among females aged 15–44 years using contraception between 2008–2010 and 2011–2013 with specific attention to associations between race, income, and age and their LARC use.

Methods: We analyzed data from two rounds of the National Survey of Family Growth, nationally representative samples of females aged 15–44 years, consisting of 6,428 females in 2008–2010 and 5,601 females in 2011–2013. We conducted simple and multivariable logistic regression analyses with adjustments for the sampling design to identify demographic characteristics predictive of LARC use and changes in these patterns between the two time periods. In this cross-sectional, descriptive study, our primary outcome of interest was current prevalence of LARC use among all contraceptive users at the time of the interview.

Results: The prevalence of LARC use among contracepting U.S. females increased from 8.5% in 2009 to 11.6% in 2012 (P<.01). The most significant increases occurred among Hispanic females (from 8.5% to 15.1%), those with private insurance (7.1–11.1%), those with fewer than two sexual partners in the previous year (9.2–12.4%), and those who were nulliparous (2.1–5.9%) (all P<.01). In multivariable analyses adjusting for key demographic characteristics, the strongest associations with LARC use in 2012 were parity (adjusted odds ratios [ORs] 4.3–5.5) and having a history of stopping non-LARC hormonal use (adjusted OR 1.9). Women aged 35–44 years (adjusted OR 0.3) were less likely to be LARC users than their counterparts (all P<.001). Poverty status was not associated with LARC use. There were no differences in discontinuation of LARC methods resulting from dissatisfaction between minority women and non-Hispanic white women.

Conclusion: During the most recent time period surveyed, use of LARC methods, particularly intrauterine devices, increased almost uniformly across the population of users.

Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009–2012

Contact the Author

Megan L. Kavanaugh , Guttmacher Institute
Printer-friendly version

Share

FacebookTwitterEmail

Topic

United States

  • Contraception: Affordable Care Act (ACA), Publicly Funded Family Planning
  • Pregnancy: Unintended Pregnancy
  • Teens: Teen Pregnancy

Geography

  • Northern America: United States
Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2022 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates